David A. Thorley-lawson
#153,324
Most Influential Person Now
David A. Thorley-lawson's AcademicInfluence.com Rankings
David A. Thorley-lawsonbiology Degrees
Biology
#11622
World Rank
#15028
Historical Rank
Virology
#282
World Rank
#289
Historical Rank
Microbiology
#665
World Rank
#734
Historical Rank
Download Badge
Biology
David A. Thorley-lawson's Degrees
- PhD Microbiology University of California, Berkeley
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is David A. Thorley-lawson Influential?
(Suggest an Edit or Addition)David A. Thorley-lawson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Functional delivery of viral miRNAs via exosomes (2010) (1479)
- A novel form of Epstein-Barr virus latency in normal B cells in vivo (1995) (1318)
- Persistence of the Epstein-Barr virus and the origins of associated lymphomas. (2004) (991)
- Epstein-Barr virus: exploiting the immune system (2001) (978)
- EBV persistence in memory B cells in vivo. (1998) (845)
- Terminal Differentiation into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In Vivo (2005) (528)
- Epstein-Barr Virus–Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients (1999) (342)
- Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo (2003) (304)
- The curious case of the tumour virus: 50 years of Burkitt's lymphoma (2008) (290)
- Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. (2001) (281)
- Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells (1985) (280)
- Identification of the Site of Epstein-Barr Virus Persistence In Vivo as a Resting B Cell (1998) (273)
- The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients (1996) (271)
- The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output (2009) (252)
- EBV Persistence--Introducing the Virus. (2015) (221)
- EBV and Systemic Lupus Erythematosus: A New Perspective1 (2005) (218)
- Is EBV persistence in vivo a model for B cell homeostasis? (1996) (212)
- Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. (1980) (200)
- The activation antigen BLAST‐2, when shed, is an autocrine BCGF for normal and transformed B cells. (1987) (192)
- All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts (1993) (190)
- Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma (2008) (190)
- Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes (1977) (189)
- The pathogenesis of Epstein-Barr virus persistent infection. (2013) (188)
- Early events in Epstein-Barr virus infection provide a model for B cell activation (1985) (186)
- Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals (1996) (185)
- BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. (1985) (184)
- Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies (1984) (179)
- Acute Infection with Epstein-Barr Virus Targets and Overwhelms the Peripheral Memory B-Cell Compartment with Resting, Latently Infected Cells (2004) (174)
- Epstein-Barr virus superinduces a new human b cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts (1982) (164)
- The dispersal of mucosal memory B cells: evidence from persistent EBV infection. (2002) (163)
- Localization of the Major NF-κB-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling Motifs* (1997) (160)
- Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. (2000) (159)
- A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. (1999) (154)
- B cell activation and the establishment of Epstein-Barr virus latency (1988) (152)
- An Epstein-Barr virus-associated superantigen (1996) (145)
- Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo (1982) (144)
- The Intersection of Epstein-Barr Virus with the Germinal Center (2009) (143)
- Cells Expressing the Epstein-Barr Virus Growth Program Are Present in and Restricted to the Naive B-Cell Subset of Healthy Tonsils (2000) (142)
- EBV the prototypical human tumor virus--just how bad is it? (2005) (141)
- Epstein-Barr Virus Infection in Ex Vivo Tonsil Epithelial Cell Cultures of Asymptomatic Carriers (2004) (140)
- Studies on the location and orientation of proteins in the sarcoplasmic reticulum. (1973) (135)
- Epstein-Barr virus and the B cell: that's all it takes. (1996) (130)
- A Novel Persistence Associated EBV miRNA Expression Profile Is Disrupted in Neoplasia (2011) (130)
- On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. (2008) (128)
- Plasma Cell-Specific Transcription Factor XBP-1s Binds to and Transactivates the Epstein-Barr Virus BZLF1 Promoter (2007) (123)
- Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene (1985) (120)
- EBV Persistence Involves Strict Selection of Latently Infected B Cells1 (2000) (115)
- Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. (2005) (111)
- Epstein-Barr-Virus-Encoded LMP2A Induces Primary Epithelial Cell Migration and Invasion: Possible Role in Nasopharyngeal Carcinoma Metastasis (2005) (109)
- The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon. (1981) (108)
- When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates (1991) (108)
- Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. (1991) (102)
- A Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis (2014) (85)
- Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein. (1987) (85)
- An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200) (1984) (84)
- The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell. (1980) (82)
- Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell (1997) (79)
- The Epstein-Barr Virus Encoded BART miRNAs Potentiate Tumor Growth In Vivo (2015) (79)
- Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein (1987) (77)
- Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein (1985) (76)
- EPSTEIN-BARR VIRUS INFECTIONS IN THE X-LINKED RECESSIVE LYMPHOPROLIFERATIVE SYNDROME (1978) (74)
- Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1 (1993) (73)
- Human Mucopolysaccharidosis IIID: Clinical, Biochemical, Morpholgical and Immunohistochemical Characteristics (1997) (73)
- Basic virological aspects of Epstein-Barr virus infection. (1988) (72)
- Germinal Center B Cells Latently Infected with Epstein-Barr Virus Proliferate Extensively but Do Not Increase in Number (2009) (72)
- Persistence of Epstein-Barr Virus in Self-Reactive Memory B Cells (2012) (69)
- The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA (1991) (69)
- The reactivity of the thiol groups of the adenosine triphosphatase of sarcoplasmic reticulum and their location on tryptic fragments of the molecule. (1977) (69)
- Simulating Epstein-Barr virus infection with C-ImmSim (2007) (66)
- Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA-3 and OX-45, and maps to chromosome 1q21-23 (1989) (66)
- Polypeptides of the Epstein-Barr virus membrane antigen complex (1979) (61)
- Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality. (2008) (61)
- Broad Cross-Reactive TCR Repertoires Recognizing Dissimilar Epstein-Barr and Influenza A Virus Epitopes (2010) (59)
- Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences (1981) (59)
- EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells (2014) (57)
- Influence of EBV on the Peripheral Blood Memory B Cell Compartment1 (2007) (56)
- Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production. (1976) (56)
- Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP (1990) (52)
- Separation and characterisation of tryptic fragments from the adenosine triphosphatase of sarcoplasmic reticulum. (1975) (50)
- Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells (1997) (48)
- Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus (1983) (47)
- Molecular cloning of the lymphocyte activation marker Blast‐1. (1987) (46)
- Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells (1979) (41)
- Epstein-Barr virus antigens-a challenge to modern biochemistry. (1982) (40)
- The Link between Plasmodium falciparum Malaria and Endemic Burkitt’s Lymphoma—New Insight into a 50-Year-Old Enigma (2016) (40)
- A virtual look at Epstein-Barr virus infection: simulation mechanism. (2008) (39)
- Varicella-zoster virus envelope glycoproteins: biochemical characterization and identification in clinical material. (1985) (39)
- Immunological responses to Epstein-Barr virus infection and the pathogenesis of EBV-induced diseases. (1989) (36)
- A Virtual Look at Epstein–Barr Virus Infection: Biological Interpretations (2007) (36)
- Biochemical analysis suggests distinct functional roles for the BLAST-1 and BLAST-2 antigens. (1986) (34)
- The Cycle of EBV Infection Explains Persistence, the Sizes of the Infected Cell Populations and Which Come under CTL Regulation (2013) (32)
- Analysis of cellular immune response to EBV by using cloned T cell lines. (1983) (32)
- An 88,000-Mr Giardia lamblia surface protein which is immunogenic in humans (1986) (29)
- Suppression of in vitro Epstein-Barr virus infection: a new role for adult human T-lymphocytes. (1978) (26)
- CD48 Binds to Heparan Sulfate on the Surface of Epithelial Cells* (1998) (26)
- An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis. (2011) (25)
- A virus-free immunogen effective against Epstein-Barr virus (1979) (24)
- Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site (1995) (21)
- Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus. (1978) (19)
- The B Cell-Restricted Glycoprotein (B2) Is the Receptor for Epstein-Barr Virus (1986) (18)
- Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48) (1991) (18)
- Surface antigen changes during B-lymphocyte activation in primates. (1984) (18)
- Structural analysis of a new B-cell-differentiation antigen associated with products of the I-A subregion of the H-2 complex. (1981) (14)
- A ligand for human CD48 on epithelial cells. (1997) (12)
- Quantitative detection of viral gene expression in populations of Epstein-Barr virus-infected cells in vivo. (2005) (12)
- Ia.W39 expression correlates with a specific Ir function. (1982) (11)
- Function of CD48 and its regulation by Epstein-Barr virus. (1993) (11)
- A new form of Epstein-Barr virus latency in vivo. (1995) (9)
- Pathogens cooperate in lymphomagenesis (2007) (8)
- Soluble CD23/BLAST-2 (S-CD23/Blast-2) and its role in B cell proliferation. (1988) (8)
- Detection and discrimination of latent and replicative herpesvirus infection at the single cell level in vivo. (2001) (7)
- Is there a unique episome in EBV transformed B cells? (1991) (7)
- IFN-alpha-stimulated genes and Epstein-Barr virus gene expression distinguish WHO type II and III nasopharyngeal carcinomas. (2007) (6)
- Mutational analysis of the transforming function of the EBV encoded LMP-1. (1992) (6)
- Detection of EBV infection at the single-cell level. Precise quantitation of virus-infected cells in vivo. (2001) (6)
- Chemotaxis in Densely Populated Tissue Determines Germinal Center Anatomy and Cell Motility: A New Paradigm for the Development of Complex Tissues (2011) (6)
- Early Events in Transformation of Human Lymphocytes by the Virus (1979) (5)
- Genomic integration as a novel mechanism of EBV persistence. (1990) (5)
- The interplay of herpesviruses in AIDS: superantigen sharing. (1996) (3)
- Characterization of genomic polymorphism of an activation-associated antigen, Blast-1 (2004) (2)
- EBV Persistence in Vivo (2002) (1)
- Monoclonal Antibody Against Ebv-Associated Transformation Antigen Detected in vitro and in vivo (1982) (1)
- IMMUNOSUPPRESSION CAUSES REACTIVATION OF EPSTEIN-BARR VIRUS AND EXPANSION OF LATENTLY INFECTED RESTING MEMORY B CELLS BUT NOT TRANSFORMED B BLASTS IN THE PERIPHERAL BLOOD. (1998) (0)
- Host EBV communication (2006) (0)
- well-known LT or ST toxins and since a mutant strain of V. cholerae deleted of the gene for the production of the ADP-ribosyl transferase enzyme subunit A of cholera toxin (12) causes diarrhea in humans, the shigella (or Shiga-like) toxin (2003) (0)
- S U P P R E S S I O N OF IN VITRO EPSTEIN-BARR VIRUS INFECTION A New Role for Adult Human T Lymphocytes* BY DAVID A. THORLEY-LAWSON, LEONARD CHESS, AND JACK L. STROMINGER (2003) (0)
- Abstract 3226: Targeting PI3K signaling in a xenograft model of nasopharyngeal carcinoma (2010) (0)
- Influenza Virus Epitopes Recognizing Dissimilar Epstein-Barr and Broad Cross-Reactive TCR Repertoires (2010) (0)
- Plasma Cell-Specific Transcription Factor XBP-1s Binds to and Transactivates the Epstein-Barr Virus BZLF1 Promoter (cid:1) (2007) (0)
- Abstract PL01-02: The mechanism of Epstein-Barr virus persistent infection and the origins of associated lymphomas (2011) (0)
- which is immunogenic in humans. An 88,000-Mr Giardia lamblia surface protein (2013) (0)
- Reaction of 1-fluoro-2,4-dinitrobenzene and 2,4,6-trinitrobenzenesulphonic acid with membranes of sarcoplasmic reticulum. (1980) (0)
- Function of CD 48 and its regulation by Epstein-Barr virus (2009) (0)
- Hemozoin is taken up by B cells and activates AID expression. (2014) (0)
- An Epstein-barrvirus-associated Superantigen (2003) (0)
- Monoclonal antibodies against the major glycoprotein ( gp 350 / 220 ) of Epstein-Barr virus neutralize infectivity ( membrane antigen / immunoprecipitation / envelope glycoprotein / transformation / virus neutralization ) (0)
- The curious case of the tumour virus: 50 years of Burkitt's lymphoma (2009) (0)
- Preliminary studies on the structure of the calcium-activated adenosine triphosphatase of sarcoplasmic reticulum. (1974) (0)
- The Mechanism of Epstein-Barr Virus Persistence in Vivo and its Relationship to the Origins of EBV Associated Lymphoma (2005) (0)
- 1768 Purification and Characterization of Shigella Toxin (2003) (0)
- THE CHEMISTRY OF THE CYSTEINE RESIDUES OF THE ATPase OF SARCOPLASMIC RETICULUM (1978) (0)
- Freeze-etching and freeze-drying in the study of sarcoplasmic reticulum vesicles and reconstituted ATPase (1974) (0)
This paper list is powered by the following services:
